Recruiting
Phase 2

MM402

Sponsor:

Mind Medicine, Inc.

Code:

NCT07303907

Conditions

Autism Spectrum Disorder

ASD

Eligibility Criteria

Sex: All

Age: 18 - 45

Healthy Volunteers: Not accepted

Interventions

MM402 (R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA))

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-28. This information was provided to ClinicalTrials.gov by Mind Medicine, Inc. on 2025-12-26.